19 June 2019
ANIMALCARE GROUP PLC
(the "Group" or the "Company"))
19 June 2019 Animalcare Group plc (AIM: ANCR), the international animal health business, announces that James Lambert has notified the Board of his intention to step down from the Board, having served as a non-executive director for sixteen years. It has been agreed that he will leave the Board with effect from the conclusion of the Annual General Meeting on 25 June 2019 ("2019 AGM").
Jan Boone, Chairman of Animalcare Group plc, said: "On behalf of the Board I would like to thank James for his significant contribution to the Group and we all wish him the best for the future."
Further to this announcement, the Board intends to withdraw resolution number 9 as set out in the Notice of Annual General Meeting dated 20 May 2019 (the "Notice") relating to James Lambert's re-election as a director.
The remaining resolutions set out in the Notice will be put to shareholders at the 2019 AGM. The withdrawal of resolution 9 does not affect the validity of the proxy form circulated to shareholders in respect of the 2019 AGM or any proxy votes already submitted.
The 2019 AGM will be held at 11:30 (GMT) on Tuesday 25 June 2019 at the offices of Panmure Gordon & Co, One New Change, London EC4M 9AF.
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.
For further information, please contact:
Animalcare Group plc
Tel: 01904 487 687
Jenny Winter, Chief Executive Officer
Chris Brewster, Chief Financial Officer
Panmure Gordon - Nominated Adviser and Broker
Tel: 020 7886 2500
Freddy Crossley / Emma Earl
Consilium Strategic Communications
Tel: 020 3709 5709
Amber Fennell /Angela Gray/Olivia Manser
About Animalcare www.animalcaregroup.co.uk
Animalcare Group plc is a UK AIM listed veterinary sales and marketing organisation resulting from the merger of Animalcare and Ecuphar NV in July 2017. Animalcare operates in 32 countries in Europe and a further 16 worldwide. The company is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.